Aberrant protein aggregation and mitochondrial dysfunction have each been linked to aging and a number of age-onset neurodegenerative disorders, including Parkinson disease. Loss-of-function mutations in parkin, an E3 ubiquitin ligase that functions to promote the ubiquitin-proteasome system of protein degradation and also in mitochondrial quality control, have been implicated in heritable forms of Parkinson disease. The question of whether parkin can modulate aging or positively impact longevity, however, has not been addressed. Here, we show that ubiquitous or neuron-specific up-regulation of Parkin, in adult Drosophila melanogaster, increases both mean and maximum lifespan without reducing reproductive output, physical activity, or food intake. Longlived Parkin-overexpressing flies display an increase in K48-linked polyubiquitin and reduced levels of protein aggregation during aging. Recent evidence suggests that Parkin interacts with the mitochondrial fission/fusion machinery to mediate the turnover of dysfunctional mitochondria. However, the relationships between parkin gene activity, mitochondrial dynamics, and aging have not been explored. We show that the mitochondrial fusionpromoting factor Drosophila Mitofusin, a Parkin substrate, increases in abundance during aging. Parkin overexpression results in reduced Drosophila Mitofusin levels in aging flies, with concomitant changes in mitochondrial morphology and an increase in mitochondrial activity. Together, these findings reveal roles for Parkin in modulating organismal aging and provide insight into the molecular mechanisms linking aging to neurodegeneration.
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energy metabolism | healthspan | mitophagy | neuronal aging | proteostasis A dvanced age is a major risk factor for many neurodegenerative disorders, including both Alzheimer's disease and Parkinson disease (PD) , and yet the molecular mechanisms that link aging and neurodegeneration are poorly understood. To understand this connection, it is necessary to identify the molecular events and pathways that integrate aging and neurodegenerative disease. Several lines of evidence suggest that a decline in the ability to prevent and eliminate protein misfolding (1) and impaired mitochondrial function (2) are important factors in the increased risk of disease and death associated with aging. More specifically, although the correlation between neurodegenerative disease and protein aggregation in the brain has long been recognized (3) , recent work in the nematode Caenorhabditis elegans (4-6) and the fruit fly Drosophila melanogaster (7) has shown that aging per se is associated with increased aggregation of a large number of proteins. At the same time, a decline in mitochondrial gene expression and/or energetic capacity is a hallmark of aging across diverse species (2, 8) , whereas a failure to eliminate dysfunctional mitochondria has been implicated in the pathophysiology of a number of neurodegenerative diseases, including PD (9) .
The ubiquitin-proteasome system (UPS) is a critical component of the cellular protein homeostasis (proteostasis) machinery and also acts in a regulatory capacity to mediate the controlled breakdown of specific proteins that impact biological processes (10) . Proteins polyubiquitinated at specific lysine residues may undergo proteasomal degradation or have nondegradative functions; K48-linked polyubiquitin chains mainly target proteins for proteasomal degradation (11) . Studies of genes involved in heritable forms of PD, including Parkin an E3 ubiquitin ligase (12) , have greatly influenced our understanding of the molecular mechanisms underlying neurodegeneration in this disorder (13) . Indeed, it has been postulated that parkin mutations impair the UPS of protein degradation, leading to the accumulation of toxic misfolded or aggregated proteins (14, 15) . More recently, considerable attention has been focused on the role of Parkin in mitochondrial quality control (MQC) (16) (17) (18) . Genetic studies in animal and cellular models, including Drosophila (19) , have shown that loss of Parkin leads to the accumulation of degenerative mitochondria (20) . The molecular basis for these findings was provided by the discovery that Parkin is recruited to dysfunctional mitochondria and targets these organelles for autophagic degradation (mitophagy) (16, 21) . In this model, PTEN-induced putative kinase (PINK) 1, a mitochondrially targeted serine/threonine kinase, is selectively stabilized on the surface of dysfunctional mitochondria, promoting the recruitment of Parkin (22) (23) (24) . Parkin then ubiquitinates the mitochondrial fusion-promoting factor Mitofusin (Mfn) (23, 25, 26) and other mitochondrial proteins (27, 28) , promoting the segregation and autophagic turnover of the dysfunctional mitochondria (16, 17) . Previous studies have reported that Parkin overexpression can ameliorate genetic and pharmacological models of both mitochondrial dysfunction (29-33) and also proteotoxicity (reviewed in ref. 34 ). However, the consequences of a long-term increase in Parkin activity, in a nondisease setting, on mitochondrial metabolism, proteostasis and organismal health are not known.
The role of Parkin in the UPS of protein turnover and in MQC, together with its connection to age-related disease, led us to examine whether Parkin could modulate organismal aging. We find that ubiquitous or neuron-specific up-regulation of Parkin can increase both mean and maximum lifespan in Drosophila. This enhanced longevity can be observed upon adult-onset induction of Parkin, indicating that it is not attributable to developmental changes. Furthermore, long-lived Parkin flies do not display major physiological tradeoffs affecting reproduction, physical activity, or feeding behavior. Parkin-mediated life extension is associated with increased K48-linked polyubiquitination and reduced levels of protein aggregation in aged flies. With respect to mitochondrial biology, we show that the Parkin substrate Drosophila (d) Mfn increases in abundance during aging. Importantly, chronic upregulation of Parkin leads to reduced levels of dMfn, mitochondrial fragmentation, and an increase in multiple markers of mitochondrial activity in aging flies. Taken together, our findings demonstrate that an increase in Parkin expression can slow aging both at the level of biochemical and molecular markers of aging and also at the organismal level by extending healthy lifespan.
Results
Adult-Onset Induction of Parkin Increases Longevity. To determine whether Parkin can modulate organismal aging, we first examined the impact of Parkin overexpression on Drosophila lifespan. Studies of the genetics of aging and lifespan determination are prone to confounding effects because of uncontrolled differences in genetic background between test and control lines (35). To confront this issue, we have used the mifepristone (RU486) inducible-GAL4 system [annotated P [Switch] or Gene-Switch (36, 37)] throughout this study. This system eliminates genetic background effects because all flies share the same genetic background and only differ with respect to the presence of the inducing agent (RU486) or diluent (ethanol) in the food. Firstly, we used the ubiquitous daughterless-Gene-Switch (daGS) driver line to activate a Upstream Activating Sequence (UAS)-parkin transgene created by Greene et al. (19) during both development and adulthood. Western blot analysis showed that Parkin is significantly overexpressed in daG-S>UAS-parkin flies upon RU486 treatment during development and the adult lifespan compared with uninduced flies (Fig. 1A and Fig. S1 A and B) . RU486 treatment had no effect on Parkin expression levels in control flies (Fig. S1 C and D) . Ubiquitous upregulation of Parkin with this driver line resulted in as much as a 28% increase in both the mean and also the maximum lifespan in female flies (Fig. 1B and Fig. S2A ) and smaller positive effects in male flies (Fig. S2 B and C) . Interestingly, lower levels of Parkin induction are sufficient to extend lifespan ( Fig. S2 D and E) , whereas increased doses of RU486 produced diminishing returns in terms of lifespan extension (Fig. S2 F and G) . No major longevity effects were observed in female or male control flies exposed to RU486 (Fig. S2 H-K) . Next, we took advantage of the inducible nature of the daGS driver to determine the temporal requirements for Parkin-mediated lifespan extension. Whereas induction of the parkin transgene exclusively during development had no major impact on adult longevity (Fig. S2L) , daGS>UAS-parkin flies were significantly longer-lived when exposed to RU486 exclusively in the adult stage (Fig. 1C) ; again, no major effects on longevity were observed in control flies exposed to RU486 using these paradigms ( Fig. S2 M and N) . Together, our data demonstrate a role for Parkin in prolonging lifespan in adult Drosophila.
Toward an initial exploration of the mechanisms underlying Parkin-mediated lifespan extension, we examined a number of behavioral and physiological parameters in long-lived Parkin flies. Because overexpression of Parkin during both development and adulthood resulted in maximum extension of lifespan, this paradigm was used in all further experiments. Long-lived Parkin flies displayed normal food consumption ( Fig. 1D and Fig. S3A ) and an increase in spontaneous physical activity in young flies (Fig. S3 B-D) . Moreover, although interventions that extend lifespan are often associated with reproductive tradeoffs (38), Parkin overexpression resulted in an increase in fecundity in young flies (Fig. S3E ). An increased capacity to withstand extrinsic stress is a hallmark of many longevity interventions (39, 40). Interestingly, Parkin-mediated longevity was not associated with increased resistance to hyperoxia (85% oxygen) (Fig. S3F) . However, long-lived Parkin flies showed improved survival when maintained on an agar-only diet to induce starvation (Fig. 1E) . Feeding RU486 to control flies (daGS>w 1118 ) did not alter feeding behavior (Fig. S3G ), physical activity ( Fig. S3 H-J), fecundity (Fig. S3K ), hyperoxia resistance (Fig. S3L ), or starvation resistance (Fig. S3M) . Taken together, our data indicate that Parkin-mediated lifespan extension is not associated with reduced feeding behavior, motor activity, or a reproductive tradeoff.
Parkin Overexpression Counteracts Age-Onset Proteotoxicity. Parkin functions as an E3 ubiquitin ligase to mediate attachment of ubiquitin monomers or chains to substrate proteins (12) . To better understand Parkin-mediated lifespan extension, we set out to examine the relationships between parkin gene activity, polyubiquitination, and aging. K48-linked polyubiquitin predominantly, but not exclusively, targets proteins for proteasomal degradation, whereas K63-linked polyubiquitin regulates protein function, subcellular localization, or protein-protein interactions (11, 41) . Firstly, we examined levels of K48-linked polyubiquitination in long-lived Parkin flies and controls during aging. Whereas no differences were observed in young flies, chronic overexpression of Parkin resulted in a significant increase in K48-linked polyubiquitination in aged flies ( Fig. 2A and quantification in Fig. S4A ). Feeding RU486 to control flies (daGS>w 1118 ) did not alter the levels of K48-linked polyubiquitination during aging ( Fig. S4 B and C) . Interestingly, however, no significant difference in the levels of K63-linked polyubiquitin chains were observed in long-lived Parkin flies (Fig. S4D) .
To determine whether Parkin-mediated lifespan extension was associated with reduced proteotoxicity during aging, we characterized the age-related deposition of protein aggregates by immunofluorescence. In agreement with previous findings (7), we observed that Drosophila flight muscles accumulate aggregates of ubiquitinated proteins during aging (compare Fig. 2 B and D) . Constitutive Parkin overexpression confers increased survival under starvation (P < 0.0001; log-rank test; n > 60 female flies). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood (A, B, D, and E) and 5 μg/mL during adulthood (C).
The cumulative area of these aggregates increases substantially with age (compare Fig. 2 F and H and see quantification in Fig. 2 J and K), consistent with a loss of proteostasis. Importantly, longlived Parkin flies displayed reduced levels of protein aggregates during aging (compare Fig. 2 D and E) and also a decrease in the size of individual aggregates (Fig. 2 H-K) . Feeding RU486 to control flies (daGS>w 1118 ) did not alter the accumulation of protein aggregates during aging (Fig. S4 E-G) . In a complementary approach, we examined the levels of insoluble ubiquitinated proteins in whole bodies of long-lived Parkin flies and controls during aging. Consistent with the immunofluorescence data, we observed that long-lived Parkin flies display reduced levels of insoluble ubiquitinated proteins during aging ( Fig. 2L and quantification in Fig. S4H ). Feeding RU486 to control flies (daGS>w
1118
) did not alter the levels of insoluble ubiquitinated proteins during aging (Fig.  S4 I and J) . Taken together, our findings indicate that up-regulation of Parkin preserves protein homeostasis during aging, which is associated with reduced levels of proteotoxicity in aged flies.
Parkin Overexpression Modulates Mitochondrial Dynamics and Activity
During Aging. In recent years, considerable attention has been focused on the role of Parkin in mediating the elimination of dysfunctional mitochondria via mitophagy (16) (17) (18) . Although the details of how this happens remain uncertain, a growing body of data supports the idea that the Parkin-mediated polyubiquitination of mitochondrial outer-membrane (OM) proteins is important for mitophagy (17) . Indeed, proteomic studies have shown that the translocation of Parkin to dysfunctional mitochondria is associated with a broad activation of the UPS, resulting in the K48-linked polyubiquitylation and degradation of many OM proteins (27) . Studies in Drosophila and mammalian cells have shown that Mfn represents an evolutionarily conserved mitochondrial substrate of Parkin (23, 25, 42) . These findings have led to the proposal that the ubiquitin-mediated turnover of Mfns would then inhibit mitochondrial fusion and, thus, promote the segregation of dysfunctional mitochondria and facilitate their clearance by mitophagy (16-18, 23, 25, 43) .
Because mitochondrial dysfunction is a hallmark of aging (2), we set out to examine the relationships between parkin gene activity, aging, and mitochondrial dynamics. In the first place, we sought to explore the effects of aging on the steady-state abundance of the dMfn. Using antibodies against dMfn (23), we examined dMfn levels in control and long-lived Parkin flies during aging. In doing so, we observed a significant increase in dMfn levels in aged control flies relative to young control flies (Fig. 3A and quantification in Fig. S5A ). Interestingly, long-lived Parkin flies displayed significantly reduced levels of dMfn at both time points. Next, we examined whether Parkin-mediated changes in dMfn levels were associated with altered mitochondrial morphology during aging. Drosophila adult flight muscle is an ideal system to study alterations in mitochondrial structure and function (44-46). In this tissue, we observed mitochondrial fragmentation (i.e., smaller and rounder mitochondria), as visualized by electron microscopy (EM), in young and aged Parkin-overexpressing flies (compare Fig. 3 B, b and D, d with Fig. 3 C, c and E, e, respectively, and quantification in Fig. 3F ). These findings are consistent with a model whereby Parkin-mediated turnover of dMfn inhibits mitochondrial fusion and, thereby, results in an increased segregation of individual mitochondria from the mitochondrial network. Feeding RU486 to control flies (daGS>w 1118 ) did not alter dMfn levels during aging (Fig. S5B ) or mitochondrial morphology (Fig. S5 C-G) .
Next, we sought to determine whether Parkin-mediated changes in mitochondrial dynamics were functionally significant. To do so, we assayed a number of markers of mitochondrial activity in longlived Parkin flies and controls during aging. Firstly, we assayed the enzymatic activity of citrate synthase, a key enzyme in the Krebs cycle and a widely used mitochondrial marker. Indeed, Parkin overexpression conferred a significant increase in citrate synthase activity both in young and aged flies (Fig. 3G) . Furthermore, longlived Parkin flies showed an increase in the activity of mitochondrial respiratory complexes I (Fig. 3H ) and complex II ( Taken together, our findings show that Parkin-mediated longevity is associated with alterations in mitochondrial dynamics and activity during aging.
Parkin Overexpression in Adult Neurons Extends Longevity. To better understand the relationships between parkin gene activity, chronic maintenance of the nervous system and organismal aging, we examined the impact of neuron-specific overexpression of Parkin on Drosophila lifespan. To do so, we used the pan-neuronal ElavGene-Switch (ElavGS) driver line to increase parkin gene expression specifically in neurons. Firstly, we validated that there was an increase in parkin gene activity in heads of ElavGS>UAS-parkin flies upon RU486 treatment ( Fig. S6 A and B) . Our previous results with the ubiquitous daGS driver line showed that increasing Parkin levels exclusively in adult tissues can extend lifespan. Therefore, we tested the effects of both constitutive and adult-onset neuronal overexpression of Parkin to refine our understanding of the spatiotemporal requirements of Parkin-mediated lifespan extension. Induced neuronal up-regulation of Parkin, both constitutively ( Fig.  4A ) and in adult neurons (Fig. 4B ), increased both mean and maximum lifespan in female flies and produced no major effect in male flies (Fig. S6C ). Other doses of RU486 gave diminishing returns in lifespan extension and higher doses shortened lifespan (Fig. S6D) . Again, no positive effects on longevity were observed in control flies exposed to RU486 using this paradigm (Fig. S6 E-G). Similar to our findings with ubiquitous overexpression, we observed that neuron-specific overexpression of Parkin did not reduce food consumption ( Fig. 4C and Fig. S7A ) or physical activity ( Fig. S7 B-D) and increased fecundity in young flies (Fig. S7E) . Interestingly, neuron-specific Parkin overexpression was sufficient to improve survival under starvation conditions (Fig. 4D) . Feeding RU486 to control flies did not alter feeding ( 
Neuronal Overexpression of Parkin Reduces Proteotoxicity and
Enhances Mitochondrial Activity in the Aging Brain. To better understand neuronal Parkin-mediated lifespan extension, we examined a number of markers of Parkin activity in heads, which are greatly enriched for neuronal tissue. Firstly, we examined levels of K48-linked polyubiquitination in heads of long-lived neuronal Parkin flies and controls during aging. Whereas no differences were observed in young flies, neuronal overexpression of Parkin resulted in a significant increase in K48-linked polyubiquitination in heads of aged flies (Fig. S8A ). To determine whether targeted activation of Parkin impacts protein homeostasis in the aging brain, we examined the levels of protein aggregates in aged brains of neuronal Parkin-overexpressing flies and controls. Long-lived flies with neuronal Parkin overexpression displayed reduced levels of protein aggregation in the aged brain ( Fig. 4E and Fig. S8C ). Feeding RU486 to control flies did not alter levels of protein aggregation in the aged brain ( Fig. S8 B and B′) . Together, these data indicate that neuronal Parkin overexpression can protect against proteotoxicity in the aging brain.
To determine whether Parkin overexpression can impact mitochondrial metabolism in aging neurons, we examined a number of markers of mitochondrial activity in heads. Interestingly, neuronal overexpression of Parkin was associated with increased citrate synthase activity ( Fig. 4F ) and dPGC-1 gene expression (Fig. S8D ) in heads of young flies and an increase in respiratory complex I activity in heads of aged flies (Fig. 4G ). Feeding RU486 to control flies (ElavGS>w
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) did not alter markers of mitochondrial activity in heads during aging ( Fig. S8 E-I ). Taken together, these findings indicate that an increase in neuronal Parkin expression protects against proteotoxicity and enhances mitochondrial activity in the aging brain. Moreover, these Parkin-mediated changes in the aging brain result in an increase in health span at the organismal level. . Data are represented as means ± SEM. RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. Young flies were 10 d of age, and old flies were 42 d of age. *P < 0.05; **P < 0.01; ***P < 0.001 (Student t test).
Discussion
In this study, we use the fruit fly D. melanogaster as a model system to address the question of whether the E3 ubiquitin ligase Parkin, previously implicated in PD, can modulate organismal aging. Using an inducible gene expression system, we show that overexpression of Parkin leads to a significant increase in longevity without any obvious physiological tradeoffs. These findings identify Parkin as a molecular link between the underlying aging process and age-onset neurodegeneration. Regarding the spatiotemporal requirements of Parkin-mediated lifespan extension, we show that adult-onset and/or neuron-specific overexpression of Parkin is sufficient to enhance longevity. However, the extent of lifespan extension was considerably greater upon ubiquitous Parkin overexpression compared with neuron-specific Parkin overexpression. Therefore, it would appear that an increase in Parkin activity beyond the nervous system is important to maximize the antiaging capabilities of Parkin. There are several apparent candidate mechanisms that could explain Parkin-mediated lifespan extension. In recent years, the idea that the accumulation of damaged or misfolded proteins (proteotoxicity) during aging is a key determinant of lifespan has gained considerable empirical support (1). Using two independent measures, we observed that Parkin overexpression reduces proteotoxicity during aging. Firstly, using immunofluorescence, we observed a reduction in the number of protein aggregates in aged flight muscle and brains of long-lived Parkin-overexpressing flies. Secondly, Western blot analysis showed reduced levels of insoluble ubiquitinated proteins in whole bodies of aged Parkinoverexpressing flies compared with uninduced controls. In C. elegans, several proteins have been identified that become aggregation-prone as a function of age (4) . An interesting area of future research will be to determine the identity of the substrates that become targeted for proteasomal degradation in response to Parkin overexpression. A related challenge will be to better understand how age-onset proteotoxicity affects the physiology of individual organ systems and how this, in turn, influences the health and viability of the organism.
A loss of mitochondrial homeostasis has been proposed as an underlying cause of aging (2) . Given the role of Parkin in mediating the clearance of dysfunctional mitochondria via mitophagy and a recent report claiming that Pink1 overexpression in dopaminergic neurons can enhance lifespan (50), it is appropriate to speculate on the role of mitochondria in Parkin-mediated lifespan extension. The process of mitophagy appears to be intimately linked to the Parkin-mediated turnover of mitochondrial OM proteins, including the mitochondrial fusion-promoting factor Mfn (17) . Our results demonstrate that dMfn shows a significant increase in abundance during aging. A previous Drosophila study reported that acute overexpression of Parkin leads to reduced dMfn levels (25) . Consistent with this, we observed that chronic overexpression of Parkin resulted in reduced dMfn levels in both young and aged flies. Moreover, we observed that the Parkin-mediated turnover of dMfn in aging flies was associated with reduced mitochondrial fusion/increased mitochondrial fission and an increase in multiple markers of mitochondrial activity. One interpretation of these findings is that Parkin overexpression leads to a more segregated mitochondrial network, thereby facilitating the clearance of damaged mitochondria via mitophagy. However, it is also possible that the observed increase in markers of mitochondrial activity in long-lived Parkin flies is attributable to an increase in mitochondrial biogenesis. Indeed, we detected a significant increase in dPGC-1 gene activity in long-lived Parkin flies. Interestingly, Parkin Interacting Substrate, PARIS (ZNF746), a repressor of mammalian PGC-1α, was recently identified as a Parkin substrate (51). Future work could focus on elucidating the relationships between Parkin, mitochondrial dynamics, mitophagy, and aging.
We have shown that long-lived Parkin flies display improved proteostasis and altered mitochondrial dynamics during aging. However, the relative contribution of each of these processes to lifespan extension remains unclear. Further study will be required to determine the cause and effects relationships between proteotoxicity, mitochondrial homeostasis, and Parkin-mediated lifespan extension. Regardless of the underlying mechanism, however, our work strongly suggests that treatments designed to augment Parkin expression during aging may delay the onset and progression of a number of age-onset diseases including, but not limited to, PD and other neurodegenerative disorders.
Materials and Methods
Below we provide a brief overview of the methods used for experiments presented in this article. For further details, please see SI Materials and Methods.
Lifespan Analysis and Physiological Assays. Lifespan analysis and other physiological assays were carried out as described previously (48). See SI Materials and Methods for details.
Immunostaining Analysis of Food Intake. Quantification of food intake was assayed at 10 d of age using two independent approaches. Firstly, food intake was assayed based upon the uptake of a blue food dye (FD&C Blue Dye No. 1; SPS Alfachem) as described in ref. 1 . Two vials of female flies of each genotype were transferred onto fresh medium containing blue dye (2.5% wt/vol) at 0900 hours for 120 min. Flies were then frozen at −80°C. Frozen flies were placed individually, after decapitation, in 1.5-mL microcentrifuge tubes and homogenized in 200 μL of deionized water. Homogenates were centrifuged at maximum speed for 10 min, 80 μL of the clear supernatant was diluted 1.5 times, and absorbance was measured at 630 nm using an Epoch spectrophotometer (BioTek). Secondly, analysis of capillary feeding ("the CAFE assay") was performed as described previously (2) with modifications. Briefly, 10 flies were placed in vials with wet tissue paper as a water source and a capillary food source [5% sucrose, 5% yeast extract, 2.5% FD&C Blue No. 1 (SPS Alfachem)]. Feeding was monitored from ∼3 h after lights on until lights off, with capillaries being replaced and feeding amounts recorded every 2-3 h.
Physical Activity. Ten adult female flies were placed in a Drosophila activity monitor (TriKinetics). Movements were recorded continuously under normal culturing conditions for 24 h on a 12-h:12-h dark:light cycle. Bar graphs represent mean activity per fly per hour for 24 h and the scatter plot shows spontaneous activity per fly during 12-h:12-h dark:light cycle. Triplicate samples were used for each activity measurement.
Hyperoxia Assay. Adult females (10 d old) in vials (10 flies per vial) on laboratory-standard food were placed in a Plexiglass enclosure at room temperature (22-24°C). Oxygen (85%) was passed through the box at a constant rate (300 mL/min).
Immunostaining, Confocal Microscopy, and Image Analysis. Hemithoraces or fly brains were dissected and fixed for 20 min in PBS with 3.7% paraformaldehyde and 0.2% Triton X-100. After washing, samples were incubated overnight at 4°C with an antibody detecting ubiquitinated proteins [1:200; mouse mAb (FK2); Enzo], washed thoroughly and incubated with secondary anti-mouse (1:250), with rhodamine phalloidin (1:200; Sigma) and/or TO-PRO-3 (1:200; Life Technologies) for 4 h at room temperature. Z-stacks were imaged using a Zeiss LSM Exciter microscope. For quantification of protein aggregates in hemithoraces, single-channel images were converted into grayscale and the size (area) and total number of protein aggregates was measured using ImageJ. For brain imaging, the middle part of lamina was selected and aggregates were imaged. For quantification, a field of (95.6 μm 2 ) was selected, and the number of aggregates was quantified using the "Find Maxima" function of ImageJ using similar threshold settings.
Western Blot. Membranes were probed with antisera against antiParkin [1:2,000 dilution; rabbit; gift from L. Pallanck (University of Washington, Seattle, WA)], anti-ubiquitin [1:1,000 dilution; Ubiquitin (P4D1) mouse mAb no. 3936; Cell Signaling], anti-K48 polyubiquitin (1:1,000 dilution; rabbit; antibody no. 4289; Cell Signaling), anti-K63 polyubiquitin (1:1,000 dilution; rabbit; D7A11 no. 5621; Cell Signaling), anti-Mitofusin (Mfn) (1:2,500 dilution; rabbit; gift from Alex Whitworth, University of Sheffield, Sheffield, UK) and horseradish peroxidase-conjugated monoclonal mouse antibody against Actin (1:5,000 dilution; Sigma). The rabbit antibodies were detected using horseradish peroxidase-conjugated anti-rabbit IgG antibodies (1:2,000 dilution; Sigma). The mouse antibodies were detected using horseradish peroxidase-conjugated anti-mouse IgG antibodies (1:2,000 dilution; Sigma). SuperSignal West Pico Chemiluminescent reagents (Thermo Fisher Scientific) were used to visualize the presence of horseradish peroxidase, and the chemiluminescent signal was recorded using a Kodak Image Station 2000R.
Western Blot Analysis of Detergent-Insoluble Fractions. Whole flies or heads were homogenized in ice-cold PBS with 1% Triton X-100 and protease inhibitors. The mixture was spun for 10 min at 4°C, and the pellet and supernatant were collected. The Triton X-100-insoluble pellet was washed and resuspended in lysis solution with 5% lithium dodecyl sulfate (LDS) (NuPAGE LDS Sample Buffer; Invitrogen).
Mitochondria Purification. Samples were gently crushed in chilled mitochondrial isolation medium (MIM) [250 mM sucrose, 10 mM Tris·HCl (pH 7.4), 0.15 mM MgCl 2 ] using a plastic pestle homogenizer and then spun twice at 500 × g for 5 min at 4°C to remove debris. The supernatant was then spun at 5, 000 × g, for 5 min at 4°C. The pellet, containing the mitochondria, was washed with MIM and resuspended in 100 μL of MIM or assay buffers. Mitochondrial purification was used for measurement of citrate synthase (CS) activity and complex I and II activity. Citrate synthase activity assay. CS activity was measured using 5 μL of purified mitochondria in a total of 95 μL of reaction solution containing 0.1 mM dithio-bis-nitrobenzoic acid (Sigma-Aldrich), 0.3 mM acetyl-CoA, 1 mM oxaloacetate, and 50 mM Tris·HCl (pH 8.0). Absorbance was measured at 412 nm every 30 s for 30 min at 25°C using an Epoch plate-reading spectrophotometer (BioTek). CS activity was normalized with protein concentrations, as determined with a μBCA kit (Thermo Fisher Scientific). Complex I and II activity assays. Complex I activity. Dilutions of mitochondrial preparations were resuspended in NADH dehydrogenase assay buffer (1× PBS, 0.35% BSA, 200 μM NADH, 240 μM KCN, 60 μM 2,6-dichloroindophenol sodium salt hydrate (DCIP), 70 μM decylubiquinone, 25 μM antimycin A) containing 2 μM rotenone or ethanol. Complex I activity was measured as the rate of decrease in absorbance at 600 nm.
Complex II activity. Dilutions of mitochondrial preparations were resuspended in succinate dehydrogenase assay buffer (1× PBS, 0.35% BSA, 2 mM EDTA, 5 mM sodium succinate, 60 μM DCIP, 25 μM antimycin A, 240 μM KCN, 2 μM rotenone, and 150 μM phenazine methosulfate). Complex II activity was measured as the rate of decrease in absorbance at 600 nm. For each assay, absorbance was measured at the given wavelength every 10 s for 30 min at 25°C using an Epoch plate-reading spectrophotometer (BioTek). Enzymatic activities were normalized to protein concentrations, as determined with a μBCA kit (Thermo Fisher Scientific) following manufacturer protocols.
Electron Microscopic Analysis. Thoraces were dissected and fixed in 2% glutaraldehyde and 2% formaldehyde overnight at 4°C. Standard procedure for electron microscopic (EM) analysis was carried out as described (3, 4) . For quantification of mitochondrial area from each micrograph, an area of 10.57 μm × 10.57 μm was selected, and the mean area of each mitochondrion (n > 81 from 3 micrographs) was measured using ImageJ.
Quantitative Real-Time PCR. Total RNA was extracted using TRIzol reagent (Invitrogen) following manufacturer protocols. Samples were treated with DNase, and then cDNA was synthesized using the standard kit (Fermentas). Equalized amplicons of Actin5C were used as a reference to normalize Drosophila (d) peroxisome proliferator-activated receptor-γ coactivator (PGC)-1 amplicons. Quantitative RT-PCR was performed using the Power SYBR Green (Applied Biosystems), and DNA amount was monitored during a 45-cycle PCR with an Applied Biosystems 7300 Thermal Cycler (Life Technologies). Primer sequences were as follows: Act5C, TTGTC-TGGGCAAGAGGATCAG and ACCACTCGCACTTGCACTT-TC; dPGC-1, GGATTCACGAATGCTAAATGTGTTCC and GATGGGTAGGATGCCGCTCAG; Parkin, CTTCAAGTGT-GCTGAGCATGT and CGGAAGCAGTCGATACAGGT.
Statistical Analysis. Unless indicated otherwise, significance was determined using a two-tailed, unpaired t test from at least three independent experiments and expressed as P values. All error bars reflect SEM. Feeding of RU486 had no effect on Parkin expression. Bar graph indicates quantification of Parkin levels. RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. Positive control indicates daGS>UAS-parkin flies fed with RU486 in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. Actin was used as a loading control. Data are represented as means ± SEM. ***P < 0.001 (Student t test). . This is an independent replicate of Fig. 1B . RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. (B) Survival curves of daGS>UAS-parkin male flies with or without RU486-mediated transgene induction. Constitutive overexpression of Parkin increases fly lifespan (P < 0.0006; log-rank test; n > 180 male flies). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. (C) Replicate survival curves of daGS>UAS-parkin male flies with or without RU486-mediated transgene induction. Constitutive overexpression of Parkin increases fly lifespan (P < 0.0001; log-rank test; n > 200 male flies). RU486 was provided in the media Legend continued on following page at 0.2 μg/mL during development and 1 μg/mL during adulthood. (D) Survival curves of daGS>UAS-parkin female flies with or without RU486-mediated transgene induction. Constitutive overexpression of Parkin with 0.2 μg/mL during development and 1 μg/mL during adulthood (black circles) increases fly lifespan (P < 0.0001; log-rank test). Lower doses of RU486 also significantly increase lifespan (P < 0.0001; log-rank test) but not to the extent of 0.2 μg/mL during development and 1 μg/mL during adulthood (white circle, 0 μg/mL during development and 0 μg/mL during adulthood; gray circle, 0.008 μg/mL during development and 0.4 μg/mL during adulthood; black circle with dot, 0.04 μg/mL during development and 0.2 μg/mL during adulthood; gray circle with dot, 0.1 μg/mL during development and 0.5 μg/mL during adulthood; n = 150 female flies). (E) Western blot analysis of Parkin expression in response to various RU486 doses in daGS>UAS-parkin and control flies (daGS>w
1118
) at 10 d of age. Bar graph indicates quantification of Parkin. RU486 was provided in the media in micrograms per milliliter during development and adulthood as indicated. Actin was used as a loading control. Data are represented as means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 (Student t test). (F) Survival curves of daGS>UAS-parkin female flies with or without RU486-mediated transgene induction. Constitutive overexpression of Parkin with the lowest dose (black circles; shown in Fig. 1B; 0. 2 μg/mL during development and 1 μg/mL during adulthood) increases fly lifespan (P < 0.0001; log-rank test). Higher doses of RU486 produced diminishing effects on lifespan extension (gray circles, 1 μg/mL during development and 5 μg/mL during adulthood; black line, 5 μg/mL during development and 25 μg/mL during adulthood; n > 200 female flies). (G) Western blot analysis of Parkin expression in response to RU486 doses from F in daGS>UAS-parkin flies at 10 d of age. Actin was used as a loading control. Data are represented as means ± SEM. *P < 0.05; **P < 0.01; ***P < 0.001 (Student t test). (H) Survival curves of control female flies (daGS>w
) with or without RU486. Feeding of RU486 had no significant effect on fly lifespan (P > 0.05; log-rank test; n > 150 female flies). RU486 was provided in the media as follows: black circles, 0.2 μg/mL during development and 1 μg/mL during adulthood; gray circles, 1 μg/mL during development and 5 μg/mL during adult; and gray asterisks, 5 μg/mL during development and 25 μg/mL during adult. (I) Survival curves of control female flies (w 1118 >UAS-parkin) with or without RU486. Feeding of RU486 had no significant effect on the fly lifespan (P = 0.0815; log-rank test; n > 150 female flies). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. (J) Survival curves of control female flies (daGS>w 1118 ) with or without RU486. Feeding of RU486 had no significant effect on fly lifespan (P > 0.05; log-rank test; n > 150 female flies). RU486 was provided in the media as follows: black circles, 0.2 μg/mL during development and 1 μg/mL during adulthood; white circle, 0 μg/mL during development and 0 μg/mL during adulthood; gray circle, 0.008 μg/mL during development and 0.4 μg/mL during adulthood; black circle with dot, 0.04 μg/mL during development and 0.2 μg/mL during adulthood; gray circle with dot, 0.1 μg/mL during development and 0.5 μg/mL during adulthood. (K) Survival curves of control male flies (daGS>w 1118 ) with or without RU486. Feeding of RU486 had no significant effect on the fly lifespan (P = 0.083; log-rank test; n > 180 male flies). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. (L) Survival curves of daGS>UAS-parkin female flies with or without RU486-mediated transgene induction. Induction of Parkin during development did not affect adult lifespan (P = 0.053; log-rank test; n > 180 female flies). RU486 was provided in the media at 0.2 μg/mL during development. (M) Survival curves of daGS>w 1118 female flies with or without RU486. Development feeding of RU486 had no effect on adult lifespan (P = 0.165 for open and black circles and P = 0.45 for open and gray circle; log-rank test; n > 180 female flies). RU486 was provided in the media at 0.2 μg/mL (black circle) and 1 μg/mL (gray circle) during development. (N) Survival curves of daGS>w 1118 female flies with or without RU486. Adult-onset feeding of RU486 had no effect on lifespan (P = 0.299 for open and black circles and P = 0.407 for open and gray circle; log-rank test; n > 180 female flies). RU486 was provided in the media at 1 μg/mL (black circle) and 5 μg/mL (gray circle) during adulthood. ) flies with or without RU486. Feeding of RU486 had no effect on survival under starvation (P > 0.05; log-rank test; n = 60 female flies). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. Data are represented as means ± SEM. ) female flies, with or without RU486. Polyubiquitin (green) immunoreactivity reveals an age-related increase in the deposition of aggregates containing polyubiquitin proteins in an RU486-independent fashion (Ea-Ed). RU486 feeding did not alter the age-related increase in the cumulative area (F) and size of protein aggregates (G). ***P < 0.001; *P < 0.05 (Student t test; n > 8; one fly per replicate). Phalloidin staining (red) outlines F-actin, which is a component of muscle myofibrils. Data are represented as means ± SEM. (Scale bar: 20 μm.) (H) Western blot detection of total polyubiquitinated proteins in whole-body detergent-insoluble extracts from aged (30 d) daGS>UAS-parkin female flies with or without RU486-mediated transgene induction. Bar graph represents quantification of Western blot using ImageJ. Actin was used as a loading control. Parkin overexpression leads to a reduction of detergent-insoluble total ubiquitin-conjugated proteins in aged flies (**P < 0.01; Student t test; n = 3; 10 flies per replicate). (I and J) Western blot detection of total polyubiquitinated proteins in whole-body detergent-insoluble extracts from young and old (10 and 30 d, respectively) daGS>w 1118 female flies with or without RU486. Bar graph represents quantification of Western blot using ImageJ. Actin was used as loading control. RU486 feeding did not alter the amounts of detergent-insoluble total ubiquitin-conjugated proteins in young (I) and old (J) flies (n = 3; 10 flies per replicate). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. Data are represented as means ± SEM. ), with or without RU486. RU486 feeding had no effect on citrate synthase activity (H), complex I activity (I), or complex II activity (J) in young or aged flies (n ≥ 3; 10 flies per replicate). (K) Quantification of dPGC-1 mRNA levels in young and aged control flies (daGS>w 1118 ), with or without RU486. Feeding of RU486 had no significant effect on the dPGC-1 expression (nonsignificant; Student t test; n = 3; five flies per replicate). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. Young flies were 10 d of age, and old flies were 42 d of age. Constitutive neuronal Parkin overexpression had no significant effect on the physical activity at young (10 d) and old (30 d) age (n = 3; 10 female flies per replicate). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. (E) Fecundity in ElavGS>UAS-parkin female flies with or without RU486-mediated transgene induction. Constitutive neuronal Parkin overexpression did not reduce egg laying at day 24 or 36, whereas on day 10 flies had higher fecundity (*P < 0.05; n ≥ 8; 10 flies per replicate). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during Legend continued on following page adulthood. (F) Food consumption (capillary feeding assay) in ElavGS>w 1118 flies with or without RU486. Feeding RU486 in control flies has no effect on food consumption (n = 10; 10 female flies per replicate). (G) Survival curves under starvation of control (ElavGS>w 1118 ) flies with or without RU486. Feeding RU486 to controls confers no survival advantage under starvation (P > 0.05; log-rank test; n = 60 female flies). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. (H-J) Spontaneous physical activity in control (ElavGS>w
) flies with or without RU486. Feeding of RU486 to control flies had no significant effect on physical activity at young (10 d) (I) and old (30 d) (J) age (n = 3; 10 flies per replicate). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. (K) Fecundity in control (ElavGS>w 1118 ) female flies with or without RU486. Feeding of RU486 had no significant effect on fecundity at 12, 24, and 36 d (n ≥ 8; 10 flies per replicate). RU486 was provided in the media at 0.2 μg/mL during development and 1 μg/mL during adulthood. Data are represented as means ± SEM. Legend continued on following page
